<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39322596</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2044-6055</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>25</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>Impact of the COVID-19 pandemic on psychotropic prescribing: a systematic review.</ArticleTitle><Pagination><StartPage>e076791</StartPage><MedlinePgn>e076791</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e076791</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2023-076791</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The global prevalence of mental health disorders has risen significantly since the beginning of the COVID-19 pandemic. The pandemic has additionally caused disruption to mental health services, leading to a shift from in-person to remote service delivery. Given its long-term impact, it has become critical to evaluate whether changes in health delivery during the pandemic have had an effect on prescribing patterns for commonly prescribed psychotropic drugs. This study aims to assess the impact of the COVID-19 pandemic on changes in psychotropic prescribing patterns in adults, as well as differences in prescribing in different healthcare delivery approaches across various geographical contexts.</AbstractText><AbstractText Label="DESIGN AND ELIGIBILITY REQUIREMENTS" NlmCategory="UNASSIGNED">Systematic review of cohort, interrupted time-series and cross-sectional studies examining prescribing trends for at least one commonly prescribed psychotropic drug during and after COVID-19 in accessing care remotely or face to face between 1 January 2020 and 17 June 2022.</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="METHODS">MEDLINE, EMBASE, CINAHL, HMIC and PsycINFO databases were searched in addition to citation chaining of relevant reviews.</AbstractText><AbstractText Label="EXTRACTION AND ANALYSIS" NlmCategory="UNASSIGNED">Study screening, data extraction and quality assessment were completed by two independent reviewers. The PECO strategy was used to devise the systematic review and findings were synthesised narratively.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">16 studies were eligible for inclusion. Studies documenting changes in psychotropic prescribing trends provided very conflicting findings. There were no stark differences in prescribing outcomes between different healthcare delivery methods (ie, face-to-face consultations vs remote consultations). A noteworthy finding was that the prescribing rate of benzodiazepines was higher in women than men. No particular trends were observed for the prescription rates of hypnotics, antidepressants or antipsychotics.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Findings support mixed trends in the prescription of psychotropic medications in a range of settings, hindering conclusive statements on COVID-19's impact on prescribing. In areas where remote consultations are in use, more comprehensive research is required to assess the safety of prescribing in these settings to inform public health policy and assess if the observed trends in our systematic review persist over time (given the increased consideration of remote and telehealth care in delivering services), particularly the safe and effective deployment of these services.</AbstractText><CopyrightInformation>© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mahesarajah</LastName><ForeName>Swettha</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-2040-9797</Identifier><AffiliationInfo><Affiliation>School of Public Health, Imperial College London Faculty of Medicine, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El Asmar</LastName><ForeName>Marie Line</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Irwin</LastName><ForeName>Ryan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Applied Health Research, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vallejo-Vaz</LastName><ForeName>Antonio J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Medicine, University of Seville, Sevilla, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mastellos</LastName><ForeName>Nikolaos</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Imperial College London, London, UK n.mastellos@imperial.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dharmayat</LastName><ForeName>Kanika I</ForeName><Initials>KI</Initials><AffiliationInfo><Affiliation>Imperial Centre for Cardiovascular Disease Prevention (ICCP), Department of Primary Care and Public Health, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011619">Psychotropic Drugs</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011619" MajorTopicYN="Y">Psychotropic Drugs</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010818" MajorTopicYN="Y">Practice Patterns, Physicians'</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001523" MajorTopicYN="N">Mental Disorders</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011307" MajorTopicYN="N">Drug Prescriptions</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008605" MajorTopicYN="N">Mental Health Services</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017216" MajorTopicYN="N">Telemedicine</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">MENTAL HEALTH</Keyword><Keyword MajorTopicYN="N">Telemedicine</Keyword></KeywordList><CoiStatement>Competing interests: RI and NM are employees of Oracle UK, a health technology organisation. AJV-V reports past or current participation in investigator-initiated research grants to Imperial College London from Pfizer, Amgen, Sanofi, MSD, Daiichi Sankyo and Regeneron, honoraria for lectures from Amgen, Mylan and Akcea, and steering committee/consulting fees from Radcliffe Cardiology and Bayer, all outside the submitted work. KID reports past or current participation in investigator-initiated research grants to Imperial College London from Amgen, Sanofi, MSD, Daiichi Sankyo and Regeneron and consulting fees from Bayer, all outside the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>4</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>22</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39322596</ArticleId><ArticleId IdType="pmc">PMC11425938</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2023-076791</ArticleId><ArticleId IdType="pii">bmjopen-2023-076791</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arias D, Saxena S, Verguet S. Quantifying the global burden of mental disorders and their economic value. E Clin Med. 2022;54:101675. doi: 10.1016/j.eclinm.2022.101675.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101675</ArticleId><ArticleId IdType="pmc">PMC9526145</ArticleId><ArticleId IdType="pubmed">36193171</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Q, Wang Y, Li J, et al. Effect of Repeated Home Quarantine on Anxiety, Depression, and PTSD Symptoms in a Chinese Population During the COVID-19 Pandemic: A Cross-sectional Study. Front Psychiatry. 2022;13:830334. doi: 10.3389/fpsyt.2022.830334.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2022.830334</ArticleId><ArticleId IdType="pmc">PMC9149163</ArticleId><ArticleId IdType="pubmed">35651827</ArticleId></ArticleIdList></Reference><Reference><Citation>Santomauro DF, Mantilla Herrera AM, Shadid J, et al. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. The Lancet. 2021;398:1700–12. doi: 10.1016/S0140-6736(21)02143-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02143-7</ArticleId><ArticleId IdType="pmc">PMC8500697</ArticleId><ArticleId IdType="pubmed">34634250</ArticleId></ArticleIdList></Reference><Reference><Citation>Inkster B, Digital Mental Health Data Insights Group (DMHDIG) Early Warning Signs of a Mental Health Tsunami: A Coordinated Response to Gather Initial Data Insights From Multiple Digital Services Providers. Front Digit Health . 2020;2:578902. doi: 10.3389/fdgth.2020.578902.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fdgth.2020.578902</ArticleId><ArticleId IdType="pmc">PMC8521957</ArticleId><ArticleId IdType="pubmed">34713053</ArticleId></ArticleIdList></Reference><Reference><Citation>Prescott K, Baxter E, Lynch C, et al. COVID-19: how prepared are front-line healthcare workers in England? J Hosp Infect. 2020;105:142–5. doi: 10.1016/j.jhin.2020.04.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhin.2020.04.031</ArticleId><ArticleId IdType="pmc">PMC7195134</ArticleId><ArticleId IdType="pubmed">32339615</ArticleId></ArticleIdList></Reference><Reference><Citation>Mind UK  https://www.mind.org.uk/news-campaigns/news/mental-health-charity-mind-finds-that-nearly-a-quarter-of-people-have-not-been-able-to-access-mental-health-services-in-the-last-two-weeks/ Available.</Citation></Reference><Reference><Citation>Ahmed S, Sanghvi K, Yeo D. Telemedicine takes centre stage during COVID-19 pandemic. BMJ Innov. 2020;6:252–4. doi: 10.1136/bmjinnov-2020-000440.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjinnov-2020-000440</ArticleId><ArticleId IdType="pubmed">37556278</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong J, Lipsitz O, Nasri F, et al. Impact of COVID-19 pandemic on mental health in the general population: A systematic review. J Affect Disord. 2020;277:55–64. doi: 10.1016/j.jad.2020.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2020.08.001</ArticleId><ArticleId IdType="pmc">PMC7413844</ArticleId><ArticleId IdType="pubmed">32799105</ArticleId></ArticleIdList></Reference><Reference><Citation>McCool A, Lukas K, Hayes P, et al. Antidepressant medication prescribing patterns in Irish general practice from 2016 to 2020 to assess for long-term use. Ir J Med Sci. 2022;191:2239–46. doi: 10.1007/s11845-021-02833-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11845-021-02833-7</ArticleId><ArticleId IdType="pmc">PMC8554180</ArticleId><ArticleId IdType="pubmed">34714490</ArticleId></ArticleIdList></Reference><Reference><Citation>Heald A, Stedman M, Farman S, et al. Seasonal Variation in Antidepressant Prescribing: Year on Year Analysis for England. Prim Care Companion CNS Disord. 2021;23:20m02790. doi: 10.4088/PCC.20m02790.</Citation><ArticleIdList><ArticleId IdType="doi">10.4088/PCC.20m02790</ArticleId><ArticleId IdType="pubmed">34000164</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Muhanna FA, Alkuwaiti AA, Alwazzeh MJ. Coronavirus disease (COVID-19) and healthcare delivery system. J Family Community Med. 2021;28:63–4. doi: 10.4103/jfcm.JFCM_572_20.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jfcm.JFCM_572_20</ArticleId><ArticleId IdType="pmc">PMC7927965</ArticleId><ArticleId IdType="pubmed">33679192</ArticleId></ArticleIdList></Reference><Reference><Citation>Badreldin HA, Atallah B. Global drug shortages due to COVID-19: Impact on patient care and mitigation strategies. Res Soc Adm Pharm. 2021;17:1946–9. doi: 10.1016/j.sapharm.2020.05.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sapharm.2020.05.017</ArticleId><ArticleId IdType="pmc">PMC7235598</ArticleId><ArticleId IdType="pubmed">32446652</ArticleId></ArticleIdList></Reference><Reference><Citation>Milani SA, Raji MA, Chen L, et al. Trends in the Use of Benzodiazepines, Z-Hypnotics, and Serotonergic Drugs Among US Women and Men Before and During the COVID-19 Pandemic. JAMA Netw Open. 2021;4:e2131012. doi: 10.1001/jamanetworkopen.2021.31012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.31012</ArticleId><ArticleId IdType="pmc">PMC8546497</ArticleId><ArticleId IdType="pubmed">34694388</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Y, Becerik-Gerber B, Lucas G, et al. Impacts of Working From Home During COVID-19 Pandemic on Physical and Mental Well-Being of Office Workstation Users. J Occup Environ Med. 2021;63:181–90. doi: 10.1097/JOM.0000000000002097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JOM.0000000000002097</ArticleId><ArticleId IdType="pmc">PMC7934324</ArticleId><ArticleId IdType="pubmed">33234875</ArticleId></ArticleIdList></Reference><Reference><Citation>Naqvi D, Perera B, Mitchell S, et al. COVID-19 pandemic impact on psychotropic prescribing for adults with intellectual disability: an observational study in English specialist community services. BJPsych Open. 2021;8:e7. doi: 10.1192/bjo.2021.1064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjo.2021.1064</ArticleId><ArticleId IdType="pmc">PMC8649353</ArticleId><ArticleId IdType="pubmed">34865678</ArticleId></ArticleIdList></Reference><Reference><Citation>Gobbi S, Płomecka MB, Ashraf Z, et al. Worsening of Preexisting Psychiatric Conditions During the COVID-19 Pandemic. Front Psychiatry. 2020;11:581426. doi: 10.3389/fpsyt.2020.581426.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2020.581426</ArticleId><ArticleId IdType="pmc">PMC7772353</ArticleId><ArticleId IdType="pubmed">33391049</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirschtritt ME, Slama N, Sterling SA, et al. Psychotropic medication prescribing during the COVID-19 pandemic. Medicine (Baltimore) 2021;100:e27664. doi: 10.1097/MD.0000000000027664.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000027664</ArticleId><ArticleId IdType="pmc">PMC8556031</ArticleId><ArticleId IdType="pubmed">34713861</ArticleId></ArticleIdList></Reference><Reference><Citation>McKee KA, Crocker CE, Tibbo PG. Long-acting injectable antipsychotic (LAI) prescribing trends during COVID-19 restrictions in Canada: a retrospective observational study. BMC Psychiatry. 2021;21:633. doi: 10.1186/s12888-021-03646-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12888-021-03646-9</ArticleId><ArticleId IdType="pmc">PMC8687150</ArticleId><ArticleId IdType="pubmed">34930204</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfschlag M, Grudet C, Håkansson A. Impact of the COVID-19 Pandemic on the General Mental Health in Sweden: No Observed Changes in the Dispensed Amount of Common Psychotropic Medications in the Region of Scania. Front Psychiatry. 2021;12:731297. doi: 10.3389/fpsyt.2021.731297.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2021.731297</ArticleId><ArticleId IdType="pmc">PMC8671297</ArticleId><ArticleId IdType="pubmed">34925084</ArticleId></ArticleIdList></Reference><Reference><Citation>Sklar M, Reeder K, Carandang K, et al. An Observational Study of the Impact of COVID-19 and the Transition to Telehealth on Community Mental Health Center Providers. Res Sq. 2020:rs.3.rs-48767. doi: 10.21203/rs.3.rs-48767/v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-48767/v1</ArticleId><ArticleId IdType="pmc">PMC7948664</ArticleId><ArticleId IdType="pubmed">33706815</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Lorenzo R, Fiore G, Bruno A, et al. Urgent Psychiatric Consultations at Mental Health Center during COVID-19 Pandemic: Retrospective Observational Study. Psychiatr Q. 2021;92:1341–59. doi: 10.1007/s11126-021-09907-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11126-021-09907-w</ArticleId><ArticleId IdType="pmc">PMC7997653</ArticleId><ArticleId IdType="pubmed">33772425</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:71.:n71. doi: 10.1136/bmj.n71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliva EM, Bowe T, Manhapra A, et al. Associations between stopping prescriptions for opioids, length of opioid treatment, and overdose or suicide deaths in US veterans: observational evaluation. BMJ. 2020:m283. doi: 10.1136/bmj.m283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m283</ArticleId><ArticleId IdType="pmc">PMC7249243</ArticleId><ArticleId IdType="pubmed">32131996</ArticleId></ArticleIdList></Reference><Reference><Citation>Olfson M, Waidmann T, King M, et al. Opioid Prescribing and Suicide Risk in the United States. Am J Psychiatry. 2023;180:418–25. doi: 10.1176/appi.ajp.22020102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.22020102</ArticleId><ArticleId IdType="pubmed">37038742</ArticleId></ArticleIdList></Reference><Reference><Citation>NIH  . Nih.gov; 2009. Study quality assessment tools | national heart, lung, and blood institute (NHLBI)https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools Available.</Citation></Reference><Reference><Citation>Balestrieri M, Rucci P, Amendola D, et al. Emergency Psychiatric Consultations During and After the COVID-19 Lockdown in Italy. A Multicentre Study. Front Psychiatry. 2021;12:697058. doi: 10.3389/fpsyt.2021.697058.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2021.697058</ArticleId><ArticleId IdType="pmc">PMC8239213</ArticleId><ArticleId IdType="pubmed">34211413</ArticleId></ArticleIdList></Reference><Reference><Citation>Estrela M, Silva TM, Gomes ER, et al. Prescription of anxiolytics, sedatives, hypnotics and antidepressants in outpatient, universal care during the COVID-19 pandemic in Portugal: a nationwide, interrupted time-series approach. J Epidemiol Community Health. 2022;76:335–40. doi: 10.1136/jech-2021-216732.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jech-2021-216732</ArticleId><ArticleId IdType="pubmed">34625519</ArticleId></ArticleIdList></Reference><Reference><Citation>Miron AA, Ifteni PI, Teodorescu A, et al. Long-Acting Injectable Antipsychotics (LAIs) Prescribing Trends during the COVID-19 Pandemic in Romania. Healthcare (Basel) 2022;10:1265. doi: 10.3390/healthcare10071265.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare10071265</ArticleId><ArticleId IdType="pmc">PMC9316377</ArticleId><ArticleId IdType="pubmed">35885792</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferro Uriguen A, Laso Lucas E, Sannino Menicucci C, et al. Psychotropic Drug Prescription in Nursing Homes During the COVID-19 Pandemic. Drugs Aging . 2022;39:467–75. doi: 10.1007/s40266-022-00948-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40266-022-00948-9</ArticleId><ArticleId IdType="pmc">PMC9208968</ArticleId><ArticleId IdType="pubmed">35726042</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabeea SA, Merchant HA, Khan MU, et al. Surging trends in prescriptions and costs of antidepressants in England amid COVID-19. Daru . 2021;29:217–21. doi: 10.1007/s40199-021-00390-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40199-021-00390-z</ArticleId><ArticleId IdType="pmc">PMC7955799</ArticleId><ArticleId IdType="pubmed">33715138</ArticleId></ArticleIdList></Reference><Reference><Citation>Campitelli MA, Bronskill SE, Maclagan LC, et al. Comparison of Medication Prescribing Before and After the COVID-19 Pandemic Among Nursing Home Residents in Ontario, Canada. JAMA Netw Open. 2021;4:e2118441. doi: 10.1001/jamanetworkopen.2021.18441.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.18441</ArticleId><ArticleId IdType="pmc">PMC8329744</ArticleId><ArticleId IdType="pubmed">34338794</ArticleId></ArticleIdList></Reference><Reference><Citation>de Dios C, Fernandes BS, Whalen K, et al. Prescription fill patterns for benzodiazepine and opioid drugs during the COVID-19 pandemic in the United States. Drug Alcohol Depend. 2021;229:109176. doi: 10.1016/j.drugalcdep.2021.109176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drugalcdep.2021.109176</ArticleId><ArticleId IdType="pmc">PMC8595244</ArticleId><ArticleId IdType="pubmed">34808468</ArticleId></ArticleIdList></Reference><Reference><Citation>Downs CG, Varisco TJ, Bapat SS, et al. Impact of COVID-19 related policy changes on filling of opioid and benzodiazepine medications. Res Soc Adm Pharm. 2021;17:2005–8. doi: 10.1016/j.sapharm.2020.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sapharm.2020.06.003</ArticleId><ArticleId IdType="pmc">PMC7738763</ArticleId><ArticleId IdType="pubmed">33317769</ArticleId></ArticleIdList></Reference><Reference><Citation>Leong C, Kowalec K, Eltonsy S, et al. Psychotropic Medication Use Before and During COVID-19: A Population-Wide Study. Front Pharmacol. 2022;13:886652. doi: 10.3389/fphar.2022.886652.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.886652</ArticleId><ArticleId IdType="pmc">PMC9092447</ArticleId><ArticleId IdType="pubmed">35571118</ArticleId></ArticleIdList></Reference><Reference><Citation>Ying LT, Yarema MC, Bousman CA. Dispensing patterns of mental health medications before and during the COVID-19 pandemic in Alberta, Canada: An interrupted time series analysis. Int J Psychiatry Med. 2023;58:172–84. doi: 10.1177/00912174221084818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00912174221084818</ArticleId><ArticleId IdType="pmc">PMC9066241</ArticleId><ArticleId IdType="pubmed">35502998</ArticleId></ArticleIdList></Reference><Reference><Citation>Kisely S, Dangelo-Kemp D, Taylor M, et al. The impact of COVID-19 on antipsychotic prescriptions for patients with schizophrenia in Australia. Aust N Z J Psychiatry . 2022;56:642–7. doi: 10.1177/00048674211025716.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00048674211025716</ArticleId><ArticleId IdType="pubmed">34240634</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . World Health Organization; 2022. WHO COVID-19 dashboard.</Citation></Reference><Reference><Citation>Morales DA, Barksdale CL, Beckel-Mitchener AC. A call to action to address rural mental health disparities. J Clin Transl Sci. 2020;4:463–7. doi: 10.1017/cts.2020.42.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/cts.2020.42</ArticleId><ArticleId IdType="pmc">PMC7681156</ArticleId><ArticleId IdType="pubmed">33244437</ArticleId></ArticleIdList></Reference><Reference><Citation>Reeves WC, Lin J-M, Nater UM. Mental illness in metropolitan, urban and rural Georgia populations. BMC Public Health. 2013;13:414. doi: 10.1186/1471-2458-13-414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2458-13-414</ArticleId><ArticleId IdType="pmc">PMC3654957</ArticleId><ArticleId IdType="pubmed">23631737</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics  . Office for National Statistics; 2021. Population estimates for the UK, England and Wales, Scotland and Northern Ireland.https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/bulletins/annualmidyearpopulationestimates/mid2020 Available.</Citation></Reference><Reference><Citation>Harman S. Ebola, gender and conspicuously invisible women in global health governance. Third World Q. 2016;37:524–41. doi: 10.1080/01436597.2015.1108827.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01436597.2015.1108827</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith J. Overcoming the ‘tyranny of the urgent’: integrating gender into disease outbreak preparedness and response. Gender &amp; Development . 2019;27:355–69. doi: 10.1080/13552074.2019.1615288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13552074.2019.1615288</ArticleId></ArticleIdList></Reference><Reference><Citation>Waheed U, Stedman M, Davies M, et al. Changes in prescribing of psychotropic vs some physical health medication in primary care through the COVID-19 pandemic in England: a national-level survey. J Pharm Policy Pract. 2023;16:169. doi: 10.1186/s40545-023-00655-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40545-023-00655-9</ArticleId><ArticleId IdType="pmc">PMC10734137</ArticleId><ArticleId IdType="pubmed">38124123</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacques-Aviñó C, López-Jiménez T, Medina-Perucha L, et al. Gender-based approach on the social impact and mental health in Spain during COVID-19 lockdown: a cross-sectional study. BMJ Open. 2020;10:e044617. doi: 10.1136/bmjopen-2020-044617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-044617</ArticleId><ArticleId IdType="pmc">PMC7688440</ArticleId><ArticleId IdType="pubmed">33234664</ArticleId></ArticleIdList></Reference><Reference><Citation>Gogia SB, Maeder A, Mars M, et al. Unintended Consequences of Tele Health and their Possible Solutions. Yearb Med Inform. 2016;25:41–6. doi: 10.15265/IY-2016-012.</Citation><ArticleIdList><ArticleId IdType="doi">10.15265/IY-2016-012</ArticleId><ArticleId IdType="pmc">PMC5171569</ArticleId><ArticleId IdType="pubmed">27830229</ArticleId></ArticleIdList></Reference><Reference><Citation>Joyce GF, Carrera MP, Goldman DP, et al. Physician prescribing behavior and its impact on patient-level outcomes. Am J Manag Care. 2011;17:e462–71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3782257</ArticleId><ArticleId IdType="pubmed">22216870</ArticleId></ArticleIdList></Reference><Reference><Citation>Han SM, Greenfield G, Majeed A, et al. Impact of Remote Consultations on Antibiotic Prescribing in Primary Health Care: Systematic Review. J Med Internet Res . 2020;22:e23482. doi: 10.2196/23482.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/23482</ArticleId><ArticleId IdType="pmc">PMC7655728</ArticleId><ArticleId IdType="pubmed">33031045</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva-Valencia J, Lapadula C, Westfall JM, et al. Effect of the COVID-19 pandemic on mental health visits in primary care: an interrupted time series analysis from nine INTRePID countries. E Clin Med. 2024;70:102533. doi: 10.1016/j.eclinm.2024.102533.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2024.102533</ArticleId><ArticleId IdType="pmc">PMC10940140</ArticleId><ArticleId IdType="pubmed">38495523</ArticleId></ArticleIdList></Reference><Reference><Citation>Galvin E, Desselle S, Gavin B, et al. Patient and provider perspectives of the implementation of remote consultations for community-dwelling people with mental health conditions: A systematic mixed studies review. J Psychiatr Res. 2022;156:668–78. doi: 10.1016/j.jpsychires.2022.10.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2022.10.051</ArticleId><ArticleId IdType="pmc">PMC9637462</ArticleId><ArticleId IdType="pubmed">36399859</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen R, Wieringa S, Greenhalgh T, et al. Clinical risk in remote consultations in general practice: findings from in-COVID-19 pandemic qualitative research. BJGP Open. 2022;6:BJGPO.2021.0204. doi: 10.3399/BJGPO.2021.0204.</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/BJGPO.2021.0204</ArticleId><ArticleId IdType="pmc">PMC9680756</ArticleId><ArticleId IdType="pubmed">35487581</ArticleId></ArticleIdList></Reference><Reference><Citation>Bystritsky A, Khalsa SS, Cameron ME, et al. Current diagnosis and treatment of anxiety disorders. P T. 2013;38:30–57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3628173</ArticleId><ArticleId IdType="pubmed">23599668</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  Adolescent mental health. 2021. https://www.who.int/news-room/fact-sheets/detail/adolescent-mental-health#:~:text=Globally%2C%20one%20in%20seven%2010 Available.</Citation></Reference><Reference><Citation>Neimann Rasmussen L, Montgomery P. The prevalence of and factors associated with inclusion of non-English language studies in Campbell systematic reviews: a survey and meta-epidemiological study. Syst Rev. 2018;7:129. doi: 10.1186/s13643-018-0786-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-018-0786-6</ArticleId><ArticleId IdType="pmc">PMC6107944</ArticleId><ArticleId IdType="pubmed">30139391</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldschmidt G, Pate MA. Every year nearly 6 million people die in developing countries from low quality healthcare - this is how we help them. WEF. 2019</Citation></Reference><Reference><Citation>McClellan M, Rajkumar R, Couch M, et al. Health Care Payers COVID-19 Impact Assessment: Lessons Learned and Compelling Needs. NAM Perspect . 2021;2021 doi: 10.31478/202105a.</Citation><ArticleIdList><ArticleId IdType="doi">10.31478/202105a</ArticleId><ArticleId IdType="pmc">PMC8406497</ArticleId><ArticleId IdType="pubmed">34532685</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>